257
Views
4
CrossRef citations to date
0
Altmetric
Letters to the Editor

Strong expression of SLAMF7 in natural killer/T-cell lymphoma and large granular lymphocyte leukemia – a prominent biomarker and potential target for anti-SLAMF7 antibody therapy

, , , , , , , & show all
Pages 3335-3338 | Received 15 Mar 2019, Accepted 19 May 2019, Published online: 04 Jun 2019
 

Acknowledgments

The authors are indebted to Angela Pries and Christina Beutel who performed SLAMF7 analysis by flow cytometer of the Department of Hematology, AK St. Georg, Hamburg, Germany.

Author contributions

AE and OW have written the paper. HS, CJ, AS, FD, MP and OW have contributed data of patients. MV and CN has performed the IHC with SLAMF7.

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article online at https://doi.org/10.1080/10428194.2019.1623887.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.